SUNHO BIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.05 HKD | +5.22% |
|
+16.34% | -.--% |
| 01:52pm | Sunho Biologics' Unit Enters Subscription Letters | MT |
| 05-24 | Hong Kong Shares End Week in Red; Sunho Biologics Gains in Debut | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Sunho Biologics Inc is a company mainly engaged in the research, development and production of biotechnology. The Company is primarily engaged in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The Company has three core products, namely IAH0968, IAP0971 and IAE0972. IAH0968 is an antibody-dependent cell-mediated cytotoxicity-enhancing monoclonal antibody. IAP0971 and IAE0972 are both antibody cytokines.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 136M | |
| +16.59% | 45.51B | |
| -9.89% | 38.52B | |
| +38.08% | 38.13B | |
| +27.12% | 30.74B | |
| -8.64% | 26.03B | |
| +11.81% | 25.92B | |
| +45.08% | 14.13B | |
| +32.85% | 12.73B | |
| -7.19% | 11.29B |
- Stock Market
- Equities
- 2898 Stock
- News Sunho Biologics, Inc.
- Sunho Biologics Shares Rise 7% in Hong Kong Debut
